Beta-lactam antibiotics were active in the majority of ALS-related assays, particularly in models related to glutamate excitotoxicity via EAAT2 and mutant SOD1 (mSOD1) toxicity [10], [11]. Here, SLC1A2 is linked to amyotrophic lateral sclerosis.